Amylase enzymes hydrolyze or digest large
polysaccharide molecules, commonly known as carbohydrates,
into small disaccharide molecules which are eventually
reduced to the mono-saccharide, glucose, before reaching the
cell. Glucose is one of the primaryraw materials used by the
body in the production of energy. The mitochondria in the
cells transform glucose into Adenosine Triphosphate (ATP), a
high-energy compound that release its energy to facilitate
cellular function. Therefore, when the body is deficient in
amylase enzymes, it is also deficient in its main source of
energy, glucose.
According to the Gell and
Coombs classification of hypersensitivity reactions, Type I
reactions result from the release of
pharmacologically-active substances such as histamine,
serotonin, slow reacting substance of anaphylaxis (SRS-A)
and eosinophilic chemotactic factor of anaphylaxis (ECF-A)
from Ige-sensitized basophils and mast cells after contact
with a specific antigen. These released substances cause
vasodilation, increased capillary permeability, smooth
muscle contraction and eosinophilia. This inflammatory
response is usually manifested in those organ systems of the
body which come in contact with the outside world, most
notably the respiratory tract and the skin. Some of the
clinical conditions in which Type I reactions play a role
include seasonal allergic rhinitis (hay fever), extrinsic
asthma, atopic dermatftis and urticaria/angicedema.
Inflammation caused by the release of histamine and similar
substances can also be triggered by trauma and acute or
chronic infections. The pharmacologically active substances
that cause an inflammatory response are stored in the
granules of mast cells or basophils until a stimulus prompts
their release. Neurohormones modulate the release of these
substances. The function of these neurohormones is
controlled by cAMP and cGMP systems within the cells.
The intracellular concentration of cAMP
is a principal determinant of both the inhibition of the
release of several chemical mediators, such as histamine,
and the relaxation of smooth muscles. The production of cAMP
and cGMP requies adequate ATP as a precursor. Therefore,
when there is a deficiency of ATP in the cell, insufficient
c AMP and cGMP will be produced causing imbalances in the
neurohormone control of inflammation. In a study reported in
Health and Longevity, a significant number of patients
exhibiting skin conditions, such as dermatitis, were found
to have low blood levels of amylase. High-potency amylase
enzymes taken between meals will be absorbed into the
bloodstream to affect the digestion of carbohydrates,
providing glucose for the production of ATP and its
subsequent conversion to cAMP and cGMP.
In
addition, amylase enzymes in the bloodstream may contribute
to the immunological attack on certain myxoviruses which are
enveloped in a coat composed principally of glycoproteins
(proteins bound to carbohydrates). These myxoviruses are
known to cause acute respiratory conditions and skin
eruptions.
Return to
Rich Distributing Enzymes Plus Intestinal Flora page